NEW YORK (360Dx) – Oxford Immunotec reported today that its third quarter revenues increased 7 percent year over year as growing product revenues offset a decline in service revenues.

For the three months ended Sept. 30, Oxford Immunotec logged $16.1 million in revenues compared to $15.0 million in the year-ago quarter, falling well short of analysts' average estimate for $33.5 million in revenues. On a constant currency basis, year-over-year revenue growth was 8 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.